Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults
Author:
Affiliation:
1. Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA
2. Division of Hematology-Oncology, University of Virginia School of Medicine, Charlottsville, VA
3. Data Science, Dana-Farber Cancer Institute, Boston, MA
Funder
Millennium/Takeda
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2018582
Reference29 articles.
1. Acute Lymphoblastic Leukemia: Older Patients and Newer Drugs
2. Treatment of Adult Acute Lymphoblastic Leukemia
3. Chemotherapy-free and reduced intensity approaches in elderly patients with B-lineage acute lymphoblastic leukemia
4. Treatment of older patients with acute lymphoblastic leukemia
5. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts;Experimental Hematology;2024-04
2. ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia;Annals of Oncology;2024-01
3. Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma;Current Hematologic Malignancy Reports;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3